Respiratory syncytial virus preterm (32-36 Completed Weeks of Gestation) risk estimation measure for RSV hospitalization in Ireland

Pediatric Infectious Disease Journal

Volumn 35, Issue 1, 2016, Pages 19-24

  Sheridan Pereira, Margaret ^a,b   Murphy, Joan ^a,b   Sloan, Julie ^a   Crispino, Gloria ^c   Leahy, Anne ^d   Corcoran, J David ^a,h   Dempsey, Eugene ^f   Elnazir, Basil ^g   Gavin, Patrick ^c,e   Sharif, Farhana ⁱ   Gul, Rizwan ^j   Satas, Salius ^k   Murphy, John ^l   Gormally, Siobhan ^m   Shanaa, Issam ⁿ   Waldron, David ^o   Mc Mahon, Paul ^p   Carson, John ^q   Blanken, Maarten ^r   Bont, Louis ^r   Paes, Bosco ^s   more..

^a Tallaght and Coombe Women's and Infant's University Hospital   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^d CAVAN GENERAL HOSPITAL   (Ireland)

^e CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^f Irish Centre for Fetal and Neonatal Translational Research   (Ireland)

^g ADELAIDE AND MEATH HOSPITAL   (Ireland)

^h ROTUNDA HOSPITAL   (Ireland)

ⁱ Midland Regional Hospital Mullingar   (Ireland)

^j Ireland johnmc cormick ucdconnectie   (Ireland)

^k Mount Carmel Hospital   (Ireland)

^l NATIONAL MATERNITY HOSPITAL   (Ireland)

^m OUR LADY OF LOURDES HOSPITAL   (Ireland)

ⁿ South Tipperary General Hospital   (Ireland)

^o St Lukes General Hospital Kilkenny   (Ireland)

^p WATERFORD REGIONAL HOSPITAL   (Ireland)

^q WEXFORD GENERAL HOSPITAL   (Ireland)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

Caucasian; late preterm infants; neonatal respiratory morbidity; respiratory syncytial virus hospitalization; risk factors

Indexed keywords

ARTICLE; CAUCASIAN; CHILD HOSPITALIZATION; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; INFANT MORTALITY; INTENSIVE CARE; IRELAND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; NEWBORN MORBIDITY; NONHUMAN; OBSERVATIONAL STUDY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; CLINICAL TRIAL; FOLLOW UP; HOSPITALIZATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK ASSESSMENT; VIROLOGY;

FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; IRELAND; MALE; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK ASSESSMENT; RISK FACTORS;

EID: 84944339803     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000918     Document Type: Article

References (41)

1. Ambrose CS, Anderson EJ, Simões EA, Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J 2014 33 576 582
2. Kramer MS, Demissie K, Yang H, The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA 2000 284 843 849
3. Langley GF, Anderson LJ., Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 2011 30 510 517
4. Wang EE, Law BJ, Stephens D., Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995 126 212 219
5. Horn SD, Smout RJ., Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr 2003 143 5 suppl S133 S141
6. Hall CB, Weinberg GA, Iwane MK, The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009 360 588 598
7. Law BJ, Carbonell-Estrany X, Simoes EA., An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002 96 suppl B S1 S7
8. Hall CB, Weinberg GA, Blumkin AK, Respiratory syncytial virus-Associated hospitalizations among children less than 24 months of age. Pediatrics 2013 132 e341 e348
9. Welliver RC Sr, Checchia PA, Bauman JH, Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Curr Med Res Opin 2010 26 2175 2181
10. Orr P, Mcdonald S, Milley D, Bronchiolitis in Inuit children from a Canadian central arctic community, 1995-1996. Int J Circumpolar Health 2001 60 649 658
11. Banerji A., High rates of hospitalisation for bronchiolitis in Inuit children on Baffin Island. Int J Circumpolar Health 2001 60 375 379
12. Szabo SM, Gooch KL, Bibby MM, The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection. Paediatr Respir Rev 2013 13 suppl 2 S1 S8
13. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 1998 102 3 Pt 1 531 537
14. Figueras-Aloy J, Carbonell-Estrany X, Quero J, IRIS Study Group Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J 2004 23 815 820
15. Law BJ, Langley JM, Allen U, The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004 23 806 814
16. Simões EA, Carbonell-Estrany X, Fullarton JR, European RSV Risk Factor Study Group A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study. Respir Res 2008 9 78-87
17. Blanken MO, Koffijberg H, Nibbelke EE, Dutch RSV Neonatal Network Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study. PLoS One 2013 8 e59161
18. Sampalis JS, Langley J, Carbonell-Estrany X, Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation. Med Decis Making 2008 28 471 480
19. Lanctôt KL, Masoud ST, Paes BA, The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis. Curr Med Res Opin 2008 24 3223 3237
20. World Health Organization WHO Child Growth Standards. Available at: www.who.int/childgrowth/en. Accessed June 26, 2013
21. Boyce TG, Mellen BG, Mitchel EF Jr, Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000 137 865 870
22. Stensballe LG, Fullarton JR, Carbonell-Estrany X, Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age. Pediatr Infect Dis J 2010 29 374 376
23. Joffe S, Escobar GJ, Black SB, Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics 1999 104 4 Pt 1 894 899
24. Doering G, Gusenleitner W, Belohradsky BH, The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age. Pediatr Infect Dis J 2006 25 1188 1190
25. Liese JG, Grill E, Fischer B, Munich RSV Study Group Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr 2003 162 230 236
26. Simoes EA, Groothuis JR., Respiratory syncytial virus prophylaxis-The story so far. Respir Med 2002 96 suppl B S15 S24
27. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, IRIS Study Group FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 2008 27 788 793
28. Nielsen HE, Siersma V, Andersen S, Respiratory syncytial virus infection-risk factors for hospital admission: a case-control study. Acta Paediatr 2003 92 1314 1321
29. Simoes EA., Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003 143 5 suppl S118 S126
30. Sommer C, Resch B, Simões EA., Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 2011 5 144 154
31. Thwaites R, Piercy J, Ryan J, Odds ratios for respiratory syncytial virus (RSV) rehospitalisation in the first 2 years of life in premature infants with and without neonatal respiratory illness. Summer Meeting Neonatal Society, 2002. Institute of Child Health. 2002 London Neonatal Society. Available at: http://www.neonatalsociety.ac.uk/abstracts/thwaitesr-2002-rsvrehospitalisation.shtml. Accessed March 17, 2014
32. Bradley JP, Bacharier LB, Bonfiglio J, Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005 115 e7 e14
33. Iwane MK, Chaves SS, Szilagyi PG, Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties-2002-2009. Am J Epidemiol 2013 22 656 665
34. Sangaré L, Curtis MP, Ahmad S., Hospitalization for respiratory syncytial virus among California infants: disparities related to race, insurance, and geography. J Pediatr 2006 149 373 377
35. Leader S, Kohlhase K., Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003 143 127 132
36. Saunders NR, Tennis O, Jacobson S, Parents' responses to symptoms of respiratory tract infections in their children. CMAJ 2003 168 25 30
37. Houben ML, Bont L, Wilbrink B, Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study. Pediatrics 2011 127 35 41
38. Nachman SA, Navaie-Waliser M, Qureshi MZ., Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: a 3-year follow-up. Pediatrics 1997 100 E8
39. Simoes EA, King SJ, Lehr MV, Preterm twins and triplets. A high-risk group for severe respiratory syncytial virus infection. Am J Dis Child 1993 147 303 306
40. Blanken MO, Rovers MM, Molenaar JM, Dutch RSV Neonatal Network. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013 368 1791 1799
41. Andabaka T, Nickerson JW, Rojas-Reyes MX, Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 2013 4 CD006602